The Association Between BRAF Mutation Class and Clinical Features in BRAF-Mutant Chinese Non-Small Cell Lung Cancer Patients

被引：0
|
作者：
Lin, Q. [1 ]
Zhu, H. [2 ]
Li, Y. [1 ]
Zhang, H. [3 ]
Ding, H. [4 ]
Qian, J. [5 ]
Han-Zhang, H. [6 ]
Lin, J. [6 ]
Xiang, J. [6 ]
机构：
[1] Wenzhou Med Univ, Affiliated Hosp 1, Dept Pulm & Crit Care Med, Wenzhou, Peoples R China
[2] Soochow Univ, Affiliated Hosp 1, Suzhou, Peoples R China
[3] Bengbu Med Coll, Affiliated Hosp 1, Bengbu, Peoples R China
[4] Ningbo Diagnost Pathol Ctr, Ningbo, Zhejiang, Peoples R China
[5] Nanjing Med Univ, Affiliated Suzhou Hosp, Suzhou, Peoples R China
[6] Burning Rock Biotech, Guangzhou, Guangdong, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
Chinese; braf; NSCLC;
D O I：
10.1016/j.jtho.2019.08.735
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.01-20
引用
收藏
页码：S363 / S363
页数：1
相关论文
共 50 条
  • [21] Clinical Characteristics and Outcomes of Patients with BRAF Mutated Non-Small Cell Lung Cancer
    Mu, Y.
    Xing, P.
    Li, Y.
    Hao, X.
    Ying, J.
    Li, J.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S868 - S868
  • [22] Clinical Significance of BRAF Gene Mutations in Patients with Non-small Cell Lung Cancer
    Kobayashi, Masashi
    Sonobe, Makoto
    Takahashi, Tsuyoshi
    Yoshizawa, Akihiko
    Ishikawa, Masashi
    Kikuchi, Ryutaro
    Okubo, Kenichi
    Huang, Cheng-Long
    Date, Hiroshi
    ANTICANCER RESEARCH, 2011, 31 (12) : 4619 - 4623
  • [23] BRAF mutations in non-small cell lung cancer
    Luk, Peter P.
    Yu, Bing
    Ng, Chiu Chin
    Mercorella, Belinda
    Selinger, Christina
    Lum, Trina
    Kao, Steven
    O'Toole, Sandra A.
    Cooper, Wendy A.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2015, 4 (02) : 142 - 148
  • [24] BRAF Inhibitors in Non-Small Cell Lung Cancer
    Sforza, Vincenzo
    Palumbo, Giuliano
    Cascetta, Priscilla
    Carillio, Guido
    Manzo, Anna
    Montanino, Agnese
    Sandomenico, Claudia
    Costanzo, Raffaele
    Esposito, Giovanna
    Laudato, Francesca
    Damiano, Simona
    Forte, Cira Antonietta
    Frosini, Giulia
    Farese, Stefano
    Piccirillo, Maria Carmela
    Pascarella, Giacomo
    Normanno, Nicola
    Morabito, Alessandro
    CANCERS, 2022, 14 (19)
  • [25] Circulating tumour DNA (ctDNA) analysis depicts mechanisms of resistance and tumour response to BRAF inhibitors in BRAF-mutant non-small cell lung cancer (NSCLC)
    Ortiz-Cuaran, S.
    Mezquita, L.
    Swalduz, A.
    Aldea, M.
    Mazieres, J.
    Jovelet, C.
    Lacroix, L.
    Pradines, A.
    Avrillon, V.
    Ouhatar, C. -MahierAit
    Hoog-Labouret, N.
    Howarth, K.
    Guichou, J-F.
    Morris, C.
    Green, E.
    Perol, M.
    Besse, B.
    Blay, J-Y.
    Saintigny, P.
    Planchard, D.
    ANNALS OF ONCOLOGY, 2019, 30 : 641 - 641
  • [26] BRAF inhibitors in advanced BRAF-positive non-small cell lung cancer
    Vavala, Tiziana
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S1323 - S1327
  • [27] Clinicopathologic characteristics and outcomes of Chinese patients with non-small-cell lung cancer and BRAF mutation
    Ding, Xi
    Zhang, Zengli
    Jiang, Tao
    Li, Xuefei
    Zhao, Chao
    Su, Bo
    Zhou, Caicun
    CANCER MEDICINE, 2017, 6 (03): : 555 - 562
  • [28] Clinical and prognostic features of patients with detailed RAS/BRAF-mutant colorectal cancer in Japan
    Ikoma, Tatsuki
    Shimokawa, Mototsugu
    Kotaka, Masahito
    Matsumoto, Toshihiko
    Nagai, Hiroki
    Boku, Shogen
    Shibata, Nobuhiro
    Yasui, Hisateru
    Satake, Hironaga
    BMC CANCER, 2021, 21 (01)
  • [29] Resistance to BRAF inhibition explored through single circulating tumour cell molecular profiling in BRAF-mutant non-small-cell lung cancer
    Mezquita, Laura
    Oulhen, Marianne
    Aberlenc, Agathe
    Deloger, Marc
    Aldea, Mihaela
    Honore, Aurelie
    Lecluse, Yann
    Howarth, Karen
    Friboulet, Luc
    Besse, Benjamin
    Planchard, David
    Farace, Francoise
    BRITISH JOURNAL OF CANCER, 2024, 130 (04) : 682 - 693
  • [30] Association between BRAF mutant classification and the efficacy of pemetrexed-based chemotherapy in Chinese advanced non-small cell lung cancer patients: a multicenter retrospective study
    Lei, Lei
    Wang, Wen-Xian
    Zhu, You-Cai
    Pu, Xing-Xiang
    Fang, Yong
    Wang, Hong
    Zhuang, Wu
    Zhang, Yin-Bin
    Wang, Li-Ping
    Xu, Chun-Wei
    Fang, Mei-Yu
    TRANSLATIONAL CANCER RESEARCH, 2020, 9 (10) : 6039 - 6049
12345